Page 305 - Multidimensional Chromatography

300 Multidimensional Chromatography

137. Z. Zhang and J. Pawlyszin, ‘Headspace solid-phase microextraction’, Anal. Chem. 65:
1843–1852 (1993).
138. E. H. M. Koster, C. Wemes, J. B. Morsink and G. J. de Jong, ‘Determination of lidocaine
in plasma by direct solid-phase microextraction combined with gas chromatography’,
J. Chromatogr. B 739:175–182 (2000).
139. S. Ulrich and J. Martens, ‘Solid-phase microextraction with capillary gas–liquid chro-
matography and nitrogen-phosphorus selective detection for the assay of antidepressant
drugs in human plasma’, J. Chromatogr. B 696:217–234 (1997).
140. M. Krogh, K. Johansen, F. Tonnesen and K. E. Rasmusen, ‘Solid-phase microextraction
for the determination of the free concentration of valproic acid in human plasma by cap-
illary gas chromatography’, J. Chromatogr. B 673:299–305 (1997).
141. W. H. J. Vaes, E. Urrestarazu Ramos, H. J. M. Verhaar, W. Seinen and J. L. M. Hermens,
‘Measurement of the free concentration using solid-phase microextraction: binding to
protein’, Anal. Chem. 68: 4463–4467 (1996).
142. I. Koide, O. Noguchi, K. Okada, A. Yokoyama, H. Oda, S. Yamamoto and H. Kataoka,
‘Determination of amphetamine and methamphetamine in human hair by headspace
solid-phase microextraction and gas chromatography with nitrogen-phosphorus detec-
tion’, J. Chromatogr. B 707:99–104(1998).
143. J.-L. Liao, C-M. Zeng, S. Hjertén and J. Pawliszyn, ‘Solid phase micro extraction of
biopolymers, exemplified with adsorption of basic proteins onto a fiber coated with
polyacrylic acid’, J. Microcolumn Sep. 8:1–4. (1996)
144. T. Greibrokk, ‘Applications of supercritical fluid extraction in multidimensional sys-
tems’, J. Chromatogr. B 703:523–536 (1995).
145. K. Hartonen and M. L. Riekkola, ‘Detection of -blockers in urine by solid-phase
extraction–supercritical fluid extraction and gas chromatography–mass spectrometry’,
J. Chromatogr. B 676:45–52 (1996).
146. D. L. Allen, K. S. Scott and J. S. Oliver, ‘Comparison of solid-phase extraction and
supercritical fluid extraction for the analysis of morphine in whole blood’, J. Anal.
Toxicol. 23:216–218 (1999).
147. L. J. Mulcahey and L. T. Taylor, ‘Supercritical fluid extraction of active components in a
drug formulation’, Anal. Chem. 64:981–984 (1992).
148. B. R. Simmons and J. T. Stewart, ‘Supercritical fluid extraction of selected pharmaceuti-
cals from water and serum’, J. Chromatogr. B 688:291–302 (1997).
149. D. A. Roston, ‘Supercritical fluid extraction-supercritical fluid chromatography for
analysis of a prostaglandin: HPMC dispersion’, Drug Dev. Ind. Pharm. 18:245–255
(1992).
150. I. J. Koski, B. A. Jansson, K. E. Markides and M. L. Lee, ‘Analysis of prostaglandins in
aqueous solutions by supercritical fluid extraction and chromatography’, J. Pharm.
Biomed. Anal. 9:281–290 (1991).
151. Q. L. Xie, K. E. Markides and M. L. Lee, ‘Supercritical fluid extraction–supercritical
fluid chromatography with fraction collection for sensitive analytes’, J. Chromatogr. Sci.
27:365–370 (1989).
152. W. M. A. Niessen, P. J. M. Bergers, U. R. Tjaden and J. van der Greef, ‘Phase-system
switching as an on-line sample pretreatment in the bioanalysis of mitomycin C using
supercritical fluid chromatography’, J. Chromatogr. 454:243–251 (1988).
153. C. M. Boone, J. C. M. Waterval, H. Lingeman, K. Ensing and W. J. M. Underberg,
‘Capillary electrophoresis as a versatile tool for the bioanalysis of drugs’, A review’,
J. Pharm. Biomed. Anal. 20:831–863 (1999).
154. W. Thormann, C. X. Zhang and A. Schmutz, ‘Capillary electrophoresis for drug analysis
in body fluids’, Ther. Drug Monit. 18:506–520 (1996).